Spoken Alpha
XOMA
XOMA Royalty Corp
Overview
XOMA Royalty Corp operates as a royalty aggregator that acquires economic rights to future milestone and royalty payments from clinical-stage and approved pharmaceutical products, providing non-dilutive funding to biotech developers.
XOMA Royalty Corp is a Healthcare company operating in Biotechnology with a $710.2M market cap.
Most recent reported earnings: Q2 FY2026 (Aug 11, 2026).
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from Unknown source, 2026-07-26.
Transcripts
Recent earnings calls
No earnings calls indexed for XOMA yet
We index calls for roughly 3,000 US-listed companies. If you'd like us to add XOMA, reply to your welcome email and we'll prioritize it.
History
Earnings history
- Q2 FY20262026-08-11EPS— vs $0.17—Rev— vs ——EODHD
- Q1 FY20262026-05-11EPS$0.17 vs $-0.06+100.0%Rev$12.3M vs ——EODHD
- Q4 FY20252026-03-17EPS$0.08 vs $-0.09+100.0%Rev$1.4M vs ——EODHD
- Q3 FY20252025-11-11EPS$0.70 vs $-0.04+100.0%Rev$9.4M vs ——EODHD
- Q2 FY20252025-08-12EPS$0.44 vs $-0.15+100.0%Rev$13.1M vs ——EODHD
- Q1 FY20252025-05-12EPS$0.06 vs $-0.27+100.0%Rev$15.9M vs ——EODHD
- Q4 FY20242025-03-05EPS$-0.06 vs $-0.30+80.2%Rev$8.7M vs ——EODHD
- Q3 FY20242024-11-06EPS$-1.59 vs $-0.41-100.0%Rev$7.2M vs ——EODHD
- Q2 FY20242024-08-12EPS$0.84 vs $-0.27+100.0%Rev$5.7M vs ——EODHD
- Q1 FY20242024-05-08EPS$-0.86 vs $-0.81-6.2%Rev$1.5M vs ——EODHD
- Q4 FY20232024-03-07EPS$-0.49 vs $-0.36-36.1%Rev$1.8M vs ——EODHD
- Q3 FY20232023-11-06EPS$-0.60 vs $-0.48-25.0%Rev$830.0K vs ——EODHD
- Q2 FY20232023-08-07EPS$-0.59 vs $-0.52-13.5%Rev$1.7M vs ——EODHD
- Q1 FY20232023-05-08EPS$-0.98 vs $-0.49-100.0%Rev$437.0K vs ——EODHD
- Q4 FY20222023-03-08EPS$-0.63 vs $-0.47-34.0%Rev$1.5M vs ——EODHD
- Q3 FY20222022-11-02EPS$-0.48 vs $-0.23-100.0%Rev$451.0K vs ——EODHD
- Q2 FY20222022-08-03EPS$-0.53 vs $-0.16-100.0%Rev$983.0K vs ——EODHD
- Q1 FY20222022-05-04EPS$-0.32 vs $-0.53+39.6%Rev$3.1M vs ——EODHD
- Q4 FY20212022-03-07EPS$1.67 vs $2.27-26.4%Rev$35.9M vs ——EODHD
- Q3 FY20212021-11-03EPS$-0.51 vs $-0.20-100.0%Rev$940.0K vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2026 | 2026-08-11 | — | $0.17 | — | — | — | — | EODHD |
| Q1 FY2026 | 2026-05-11 | $0.17 | $-0.06 | +100.0% | $12.3M | — | — | EODHD |
| Q4 FY2025 | 2026-03-17 | $0.08 | $-0.09 | +100.0% | $1.4M | — | — | EODHD |
| Q3 FY2025 | 2025-11-11 | $0.70 | $-0.04 | +100.0% | $9.4M | — | — | EODHD |
| Q2 FY2025 | 2025-08-12 | $0.44 | $-0.15 | +100.0% | $13.1M | — | — | EODHD |
| Q1 FY2025 | 2025-05-12 | $0.06 | $-0.27 | +100.0% | $15.9M | — | — | EODHD |
| Q4 FY2024 | 2025-03-05 | $-0.06 | $-0.30 | +80.2% | $8.7M | — | — | EODHD |
| Q3 FY2024 | 2024-11-06 | $-1.59 | $-0.41 | -100.0% | $7.2M | — | — | EODHD |
| Q2 FY2024 | 2024-08-12 | $0.84 | $-0.27 | +100.0% | $5.7M | — | — | EODHD |
| Q1 FY2024 | 2024-05-08 | $-0.86 | $-0.81 | -6.2% | $1.5M | — | — | EODHD |
| Q4 FY2023 | 2024-03-07 | $-0.49 | $-0.36 | -36.1% | $1.8M | — | — | EODHD |
| Q3 FY2023 | 2023-11-06 | $-0.60 | $-0.48 | -25.0% | $830.0K | — | — | EODHD |
| Q2 FY2023 | 2023-08-07 | $-0.59 | $-0.52 | -13.5% | $1.7M | — | — | EODHD |
| Q1 FY2023 | 2023-05-08 | $-0.98 | $-0.49 | -100.0% | $437.0K | — | — | EODHD |
| Q4 FY2022 | 2023-03-08 | $-0.63 | $-0.47 | -34.0% | $1.5M | — | — | EODHD |
| Q3 FY2022 | 2022-11-02 | $-0.48 | $-0.23 | -100.0% | $451.0K | — | — | EODHD |
| Q2 FY2022 | 2022-08-03 | $-0.53 | $-0.16 | -100.0% | $983.0K | — | — | EODHD |
| Q1 FY2022 | 2022-05-04 | $-0.32 | $-0.53 | +39.6% | $3.1M | — | — | EODHD |
| Q4 FY2021 | 2022-03-07 | $1.67 | $2.27 | -26.4% | $35.9M | — | — | EODHD |
| Q3 FY2021 | 2021-11-03 | $-0.51 | $-0.20 | -100.0% | $940.0K | — | — | EODHD |
Source: EODHD. XOMA reported actuals as published; sparse fields render as —.
Top executives
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
- Owen HughesCEO2 yr 10 mono recorded callsCurrent
- Jeffrey TrigilioCFO10 mono recorded callsCurrent
- Thomas M BurnsCFO9 yrno recorded callsCurrent
- Maricel Perea MontanoChief Legal Officer1 yr 3 mono recorded callsCurrent
- Bradley SitkoChief Investment Officer3 yr 10 mono recorded callsCurrent
- James R NealCEO0 mono recorded callsFormer
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for XOMA.
$ curl https://api.spokenalpha.com/v1/companies/XOMAFAQ
Frequently asked about XOMA
Where can I find XOMA Royalty Corp's (XOMA) earnings call transcripts?
Spoken Alpha indexes XOMA's earnings call transcripts at https://spokenalpha.com/companies/XOMA. Each call links to attributed speakers and parsed analyst Q&A. XOMA Royalty Corp's own investor relations page is at https://investors.xoma.com/.
What sector is XOMA in?
XOMA Royalty Corp (XOMA) operates in the Healthcare sector (Biotechnology industry).